Information Summaries from PDQ
- Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)
[ patient ] 1 [ health professional ] 2
Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia. - Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)
[ patient ] 3 [ health professional ] 4
Expert-reviewed information summary about the treatment of childhood acute lymphoblastic leukemia. - Adult Acute Myeloid Leukemia Treatment (PDQ®)
[ patient ] 5 [ health professional ] 6
Expert-reviewed information summary about the treatment of adult acute myeloid leukemia. - Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)
[ patient ] 7 [ health professional ] 8
Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders. - Chronic Lymphocytic Leukemia Treatment (PDQ®)
[ patient ] 9 [ health professional ] 10
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia. - Chronic Myelogenous Leukemia Treatment (PDQ®)
[ patient ] 11 [ health professional ] 12
Expert-reviewed information summary about the treatment of chronic myelogenous leukemia. - Hairy Cell Leukemia Treatment (PDQ®)
[ patient ] 13 [ health professional ] 14
Expert-reviewed information summary about the treatment of hairy cell leukemia.
Drug Information
- Drugs Approved for Leukemia 15
This page lists cancer drugs approved by the FDA for use in leukemia. The drug names link to NCI's Cancer Drug Information summaries. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters.
Clinical Trials
- Clinical Trials to Treat Adult Acute Lymphoblastic Leukemia 16
Check for adult acute lymphoblastic leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features. - Clinical Trials to Treat Childhood Acute Lymphoblastic Leukemia 17
Check for childhood acute lymphoblastic leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features. - Clinical Trials to Treat Adult Acute Myeloid Leukemia 18
Check for adult acute myeloid leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features. - Clinical Trials to Treat Childhood Acute Myeloid Leukemia 19
Check for childhood acute myeloid leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features. - Clinical Trials to Treat Chronic Lymphocytic Leukemia 20
Check for chronic lymphocytic leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features. - Clinical Trials to Treat Chronic Myelogenous Leukemia 21
Check for chronic myelogenous leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features. - Clinical Trials to Treat Hairy Cell Leukemia 22
Check for hairy cell leukemia treatment trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
Research Findings
- Patients Taking Imatinib for CML Have Similar Risk of Death as General Population 23
In an international study, the risk of death for chronic myelogenous leukemia patients treated with imatinib (Gleevec) who had been in remission for at least 2 years was not different from that of the general population, according to an article in the March 21, 2011 issue of the Journal of the National Cancer Institute. - Donated Stem Cell Transplants Better than Self-transplants for Most Patients with AML 24
Evidence from a meta-analysis of prospective clinical trials supports the use of donated (or allograft) stem cell transplants to treat most individuals with acute myeloid leukemia, according to the June 10, 2009, Journal of the American Medical Association.
Related Treatment Information
- Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation 25
A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits. - Childhood Hematopoietic Cell Transplantation (PDQ®)
[ health professional ] 26
Expert-reviewed information summary about the use of hematopoietic cell transplantation in treating childhood cancer. - Targeted Cancer Therapies 27
A fact sheet that describes targeted cancer therapies, which are drugs that block the growth and spread of cancer by interfering with specific molecules involved in carcinogenesis (the process by which normal cells are transformed into cancer cells) and tumor growth. - Biological Therapies for Cancer 28
A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies. - Biological Therapy 29
An introduction to biological therapy to help patients prepare to receive it for cancer treatment or managing side effects.